CLINDAMYCIN HYDROCHLORIDE
- Product NDC
- 51655-710
- 11-digit product format
- 516550710
- Labeler code
- 51655
- Product ID
- 51655-710_4b94aa4e-1bc6-a2df-e063-6294a90a3944
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA207402
- Marketing category
- ANDA
- Marketing start
- 2023-02-03
- Substance
- CLINDAMYCIN HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CLINDAMYCIN HYDROCHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CLINDAMYCIN HYDROCHLORIDE | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | T20OQ1YN1W |
| Rxcui | 197518 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51655-710-52 | 51655071052 | 30 CAPSULE in 1 BOTTLE, PLASTIC (51655-710-52) | 30 capsule | 2023-02-03 | No | No | Historical |